Global Hormonal Contraceptives Market 2024-2028
Hormonal Contraceptives Market 2024-2028
The hormonal contraceptives market is forecasted to grow by USD 4350.8 mn during 2023-2028, accelerating at a CAGR of 4.2% during the forecast period. The report on the hormonal contraceptives market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in unplanned pregnancies, initiatives by government and non-profit organizations, and increasing adoption of innovative marketing strategies.
Technavio's hormonal contraceptives market is segmented as below:
By Method
- Oral contraceptives
- Implanted contraceptives
- Injected contraceptives
- Intrauterine
- Others
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
This study identifies the importance of family planning in developing countries as one of the prime reasons driving the hormonal contraceptives market growth during the next few years. Also, rising disposable income and technological advances will lead to sizable demand in the market.
The report on the hormonal contraceptives market covers the following areas:
- Hormonal Contraceptives Market sizing
- Hormonal Contraceptives Market forecast
- Hormonal Contraceptives Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hormonal contraceptives market vendors that include AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Biolab Sanus Farmaceutica Ltda, Cipla Inc., Facmed Pharma, Glenmark Pharmaceuticals Ltd., Healing Pharma India Pvt. Ltd., HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Mayne Pharma Group Ltd., Merck and Co. Inc., Mylan, Organon and Co., Pfizer Inc., Pregna International, Teva Pharmaceutical Industries Ltd., and TherapeuticsMD. Also, the hormonal contraceptives market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.